Neurology & Neurotherapeutics

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Stroke 96%
3. Brain 69%
4. Alzheimer Disease 59%
5. Therapeutics 47%
6. Seizures 38%
7. Cognitive Dysfunction 37%
8. Mutation 37%
9. Epilepsy 30%
10. Memory 30%
11. Magnetic Resonance Imaging 29%
12. Genes 29%
13. Muscles 29%
14. Cerebrovascular Circulation 29%
15. Proteins 26%
16. LDL Receptors 26%
17. Parkinson Disease 24%
18. Neurons 23%
19. Low Density Lipoprotein Receptor-Related Protein-1 22%
20. Exercise 22%
21. Lipoprotein Receptors 22%
22. Dementia 21%
23. Depression 21%
24. Child 20%
25. Pediatrics 20%
26. Antibodies 20%
27. Electroencephalography 20%
28. Skeletal Muscle 20%
29. Essential Tremor 19%
30. Spinal Muscular Atrophy 19%
31. Glioblastoma 19%
32. Placebos 19%
33. Wounds and Injuries 19%
34. Safety 19%
35. Central Nervous System 19%
36. Cognition 18%
37. Amyloid 18%
38. Phenotype 18%
39. Traumatic Brain Injury 18%
40. Electroconvulsive Therapy 18%
41. Nervous System 17%
42. Neurology 17%
43. White Matter 17%
44. Glioma 16%
45. Clinical Trials 16%
46. Blood Pressure 16%
47. Neuromyelitis Optica 16%
48. Membranes 16%
49. Biomarkers 16%
50. Registries 16%
51. Glycogen Storage Disease Type V 16%
52. Homeostasis 15%
53. Cerebrospinal Fluid 15%
54. Neoplasms 15%
55. Cyclin-Dependent Kinase 5 15%
56. Tissue Plasminogen Activator 15%
57. LDL-Receptor Related Proteins 14%
58. Population 14%
59. Migraine Disorders 14%
60. Cerebral Hemorrhage 14%
61. Guidelines 14%
62. Subarachnoid Hemorrhage 14%
63. Urodynamics 14%
64. Eye 14%
65. Pathology 14%
66. Tuberous Sclerosis 14%
67. Nervous System Diseases 13%
68. Headache 13%
69. low density lipoprotein receptor-related protein 8 13%
70. Randomized Controlled Trials 13%
71. Neuroimaging 13%
72. Magnetic Resonance Spectroscopy 13%
73. Arterial Pressure 13%
74. Apolipoproteins E 13%
75. Pseudotumor Cerebri 13%
76. Semantics 13%
77. Myasthenia Gravis 13%
78. Neurodegenerative Diseases 13%
79. Glucose 12%
80. Nerve Fibers 12%
81. Natalizumab 12%
82. Intracranial Pressure 12%
83. Optical Coherence Tomography 12%
84. Brain Injuries 12%
85. Brain Neoplasms 11%
86. Major Depressive Disorder 11%
87. Cholinergic Receptors 11%
88. T-Lymphocytes 11%
89. Mental Status and Dementia Tests 11%
90. Blood Flow Velocity 11%
91. Muscular Diseases 11%
92. Stress Urinary Incontinence 11%
93. Blood Vessels 11%
94. Duchenne Muscular Dystrophy 11%
95. Quality of Life 11%
96. Oxygen 11%
97. B-Lymphocytes 11%
98. Hippocampus 11%
99. Pharmaceutical Preparations 11%
100. Tremor 10%